Stock Price Quote

NURECA LTD.

NSE : NURECABSE : 543264ISIN CODE : INE0DSF01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE301.85-9.35 (-3 %)
PREV CLOSE ( ) 311.20
OPEN PRICE ( ) 305.00
BID PRICE (QTY) 301.45 (21)
OFFER PRICE (QTY) 301.85 (11)
VOLUME 3174
TODAY'S LOW / HIGH ( )298.50 313.90
52 WK LOW / HIGH ( )283.45 468.25
NSE300.15-12.25 (-3.92 %)
PREV CLOSE( ) 312.40
OPEN PRICE ( ) 308.85
BID PRICE (QTY) 300.15 (13)
OFFER PRICE (QTY) 300.90 (3)
VOLUME 29009
TODAY'S LOW / HIGH( ) 300.00 318.00
52 WK LOW / HIGH ( )284.25 468.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-11 2016
Management Info
Saurabh Goyal - Chairman Saurabh Goyal - Managing Director
Registered Office

Address Office No. 101, 1st Floor,Udyog Bhavan Sonawala Lane,Goregaon East,
Mumbai,
Maharashtra-400063

Phone 0172-5292900

Email cs@nureca.com

Website www.nureca.com

Registrars Details
Alankit Assignments Ltd.
205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi
Listing : BSE, NSE

NEWS

01Mar Nureca informs about press release
Nureca has informed that it attached Press Release titled ‘Dr Trust rank..
08Feb Nureca informs about press release
Nureca has informed that it enclosed Newspaper Publication of the unaudi..
17May Nureca informs about secretarial compl
Pursuant to the Regulation 24A of SEBI (Listing Obligations and Disclosu..
28Jan Nureca informs about board meeting
Nureca has informed that the meeting of the Board of Directors of the Co..
26Nov Nureca informs about disclosure of rel
Pursuant to Regulation 23(9) of the Securities and Exchange Board of Ind..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit0.780000000000008-84.22
Gross Profit 8.30000000000001 -109.57
Operating Profit 14.93-82.25
Net Sales 223.741118.99

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kretto Syscon (BSE)
peergroup  0.87 (4.82%)
M.Cap ( in Cr)13.64
GKB Ophthalmics (BSE)
peergroup  76.97 (-0.31%)
M.Cap ( in Cr)37.93
Raaj Medisafe India (BSE)
peergroup  47.01 (-2.10%)
M.Cap ( in Cr)52.49
Centenial Surgical (BSE)
peergroup  92.80 (-1.22%)
M.Cap ( in Cr)32.83
Prevest Denpro (BSE)
peergroup  353.00 (-0.38%)
M.Cap ( in Cr)426.11

Shareholding Pattern

PROMOTERS 63.24%
NON-INSTITUTION 36.69%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Nureca Ltd.

Nureca Ltd. was incorporated in the year 2016. Its today's share price is 301.85. Its current market capitalisation stands at Rs 307.86 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1171.53 Cr and Total Income of Rs.1190.64 Cr. The company's management includes Chetna Anand, Rajinder Sharma, Aryan Goyal, Ruchita Agarwal, Charu Singh, Shrikant Uttam Tamhane, Vikram Chaudhery, Vijay Kumar Sharma, Saurabh Goyal, Saurabh Goyal.

It is listed on the BSE with a BSE Code of 543264 , NSE with an NSE Symbol of NURECA and ISIN of INE0DSF01015. It's Registered office is at Office No. 101, 1st Floor,Udyog Bhavan Sonawala Lane,Goregaon EastMumbai-400063, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.